DLK1 promotes lung cancer cell invasion through upregulation of MMP9 expression depending on Notch signaling

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Li, Lin ^a   Tan, Jinjing ^a   Zhang, Ying ^a   Han, Naijun ^a   Di, Xuebing ^a   Xiao, Ting ^a   Cheng, Shujun ^a   Gao, Yanning ^a   Liu, Yu ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA LIKE 1 HOMOLOG PROTEIN; EPIDERMAL GROWTH FACTOR; GELATINASE B; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; DLK1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NOTCH RECEPTOR; SIGNAL PEPTIDE;

ARTICLE; CANCER CELL; CELL INVASION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; NOTCH INTRACELLULAR DOMAIN; NOTCH SIGNALING PATHWAY; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; UPREGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; EXTRACELLULAR MATRIX; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84897988884     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091509     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96. (Pubitemid 351521864)
2. Herbst RS, Lippman SM (2007) Molecular signatures of lung cancer - toward personalized therapy. N Engl J Med 356: 76-78. (Pubitemid 46041757)
3. Glittenberg M, Pitsouli C, Garvey C, Delidakis C, Bray S (2006) Role of conserved intracellular motifs in Serrate signalling, cis-inhibition and endocytosis. EMBO J 25: 4697-4706. (Pubitemid 44607016)
4. Bray SJ, Takada S, Harrison E, Shen SC, Ferguson-Smith AC (2008) The atypical mammalian ligand Delta-like homologue 1 (Dlk1) can regulate Notch signalling in Drosophila. BMC Dev Biol 8: 11.
5. Nueda ML, Baladron V, Sanchez-Solana B, Ballesteros MA, Laborda J (2007) The EGF-like protein dlk1 inhibits notch signaling and potentiates adipogenesis of mesenchymal cells. J Mol Biol 367: 1281-1293. (Pubitemid 46413261)
6. Nueda ML, Garcia-Ramirez JJ, Laborda J, Baladron V (2008) dlk1 specifically interacts with insulin-like growth factor binding protein 1 to modulate adipogenesis of 3T3-L1 cells. J Mol Biol 379: 428-442.
7. Wang Y, Sul HS (2009) Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab 9: 287-302.
8. Sul HS (2009) Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. Mol Endocrinol 23: 1717-1725.
9. Abdallah BM, Boissy P, Tan Q, Dahlgaard J, Traustadottir GA, et al. (2007) dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors. J Biol Chem 282: 7339-7351. (Pubitemid 47093687)
10. Li L, Forman SJ, Bhatia R (2005) Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation. Oncogene 24: 4472-4476. (Pubitemid 40961770)
11. Begum A, Kim Y, Lin Q, Yun Z (2012) DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo. Cancer Lett 318: 26-33.
12. Xu X, Liu RF, Zhang X, Huang LY, Chen F, et al. (2012) DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma. Mol Cancer Ther 11: 629-638.
13. Yu F, Hao X, Zhao H, Ge C, Yao M, et al. (2010) Delta-like 1 contributes to cell growth by increasing the interferon-inducible protein 16 expression in hepatocellular carcinoma. Liver Int 30: 703-714.
14. Yin D, Xie D, Sakajiri S, Miller CW, Zhu H, et al. (2006) DLK1: increased expression in gliomas and associated with oncogenic activities. Oncogene 25: 1852-1861.
15. Ceder JA, Jansson L, Helczynski L, Abrahamsson PA (2008) Delta-like 1 (Dlk-1), a novel marker of prostate basal and candidate epithelial stem cells, is downregulated by notch signalling in intermediate/transit amplifying cells of the human prostate. Eur Urol 54: 1344-1353.
16. Liu Y, Tan J, Li L, Li S, Zou S, et al. (2010) [Study on the molecular mechanisms of dlk1 stimulated lung cancer cell proliferation]. Zhongguo Fei Ai Za Zhi 13: 923-927.
17. Falix FA, Aronson DC, Lamers WH, Gaemers IC (2012) Possible roles of DLK1 in the Notch pathway during development and disease. Biochim Biophys Acta 1822: 988-995.
18. Sanchez-Solana B, Nueda ML, Ruvira MD, Ruiz-Hidalgo MJ, Monsalve EM, et al. (2011) The EGF-like proteins DLK1 and DLK2 function as inhibitory non-canonical ligands of NOTCH1 receptor that modulate each other's activities. Biochim Biophys Acta 1813: 1153-1164.
19. Baladron V, Ruiz-Hidalgo MJ, Nueda ML, Diaz-Guerra MJ, Garcia-Ramirez JJ, et al. (2005) dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp Cell Res 303: 343-359. (Pubitemid 40126268)
20. Bin Hafeez B, Adhami VM, Asim M, Siddiqui IA, Bhat KM, et al. (2009) Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 15: 452-459.
21. Ma Y, Lin D, Sun W, Xiao T, Yuan J, et al. (2006) Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer. Clin Cancer Res 12: 1121-1127. (Pubitemid 43342499)
22. Huang J, Zhang X, Zhang M, Zhu JD, Zhang YL, et al. (2007) Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma. Carcinogenesis 28: 1094-1103. (Pubitemid 47072196)
23. Kawakami T, Chano T, Minami K, Okabe H, Okada Y, et al. (2006) Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Hum Mol Genet 15: 821-830. (Pubitemid 43338225)
24. Stylianou S, Clarke RB, Brennan K (2006) Aberrant activation of notch signaling in human breast cancer. Cancer Res 66: 1517-1525. (Pubitemid 43259933)
25. Chu D, Zhang Z, Zhou Y, Wang W, Li Y, et al. (2011) Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer. Ann Oncol.
26. Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT, et al. (2010) Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer 116: 5676-5685.
27. Eliasz S, Liang S, Chen Y, De Marco MA, Machek O, et al. (2010) Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene 29: 2488-2498.
28. Kim KA, Kim JH, Wang Y, Sul HS (2007) Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol Cell Biol 27: 2294-2308. (Pubitemid 46418483)
29. Wang Y, Zhao L, Smas C, Sul HS (2010) Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol Cell Biol 30: 3480-3492.